Skip to content

Author

D. Divakaran

We have 5 of 28 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Apr 2026

Association of oxidative stress, inflammation, and ADIPOQ gene expression in young adults at risk of non-alcoholic fatty liver disease and cardiovascular disease

Introduction non-alcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVD) are increasingly seen in young adults due to obesity, sedentary lifestyle, and poor diet. Oxidative stress and chronic inflammation are key contributors to their development, promoting liver damage, endothelial dysfunction, and ath...

Rachana Raveendran, A. Josephine, V. Sureka et al. · 0 citations
Open access Aug 2026

Comprehensive analysis of HLA-G expression, hormonal profiles, and inflammatory markers in women with recurrent pregnancy loss

Investigating the role of Human Leukocyte Antigen-G gene expression, inflammatory cytokines, and hormonal profiles in the pathogenesis of recurrent pregnancy loss highlighted the interplay between immune dysfunction, hormonal imbalance, and reduced HLA-G expression in RPL.

Simi Nadarajan, Arumugam Suresh, D. Divakaran et al. · 0 citations
Open access Aug 2026

LEPTIN RECEPTOR GENE EXPRESSION AND ITS ASSOCIATION WITH CARDIOVASCULAR RISK MARKERS IN OBESE SUBJECTS: A CASE–CONTROL STUDY FROM SOUTH INDIA

Background: Obesity is a major global health concern associated with chronic inflammation, metabolic dysregulation, and an increased risk of cardiovascular disease (CVD). Altered leptin receptor (LEPR) signalling has been implicated in obesity-related cardiometabolic complications; however, evidence regarding LEPR gene...

Swathi Thoduvayil, Mohana Thiruchenduran, D. Divakaran et al. · 0 citations
Aug 2026

Dysregulation of IL-6 and IL-10 Gene Expression in Cardiometabolic Syndrome and Heart Failure

Combined assessment of IL-10 gene expression, CRP, and NT-proBNP may improve inflammatory–cardiac risk stratification in CMS and significantly associated with the presence of HF among patients with CMS.

H. Haridas, Puvvada Sravanthi, S. Saravana Kumar et al. · 0 citations
Open access Jul 2026

Association of APOE gene expression with thyroid dysfunction, inflammation, and nitrosative stress in cardiometabolic syndrome: a case–control study

CMS is characterized by the convergence of thyroid dysregulation, inflammation, oxidative stress, and increased ApoE gene expression, which highlights a coordinated molecular network underlying CMS and support the integration of molecular and inflammatory biomarkers into cardiometabolic risk assessment.

Tha-alnoorein Abdulla, T. Kumar D, J. Inbanathan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.